Company / PP&E per Share
PLIANT THERAPEUTICS, INC. PP&E per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.05
FY2025
5-year range
$0.05 / $0.13
FY2021-FY2025
Trend
-47.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $0.07 to $0.05 over the past 2 years.
Based on SEC 10-K filings.
0.05 in FY2025 with a 5-year CAGR of -54.0%.
Declined from $0.07 to $0.05 over the past 2 years.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -27.0%
- 5-Year CAGR
- -54.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, pp&e per share decreased 47.6% year-over-year.
- Peak pp&e per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -4.20 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.05 | -47.6% |
| FY2024 | $0.09 | +26.5% |
| FY2023 | $0.07 | -41.4% |
| FY2022 | $0.12 | -4.0% |
| FY2021 | $0.13 | -94.5% |
| FY2020 | $2.34 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026